Adma Biologics Inc (ADMA)

May 28, 2025

ADMA Biologics vs. Grifols: Which Plasma Therapy Stock Is the Better Buy? - sharewise

May 28, 2025

May 28, 2025

ADMA Biologics Vs. Grifols: Which Plasma Therapy Stock Is The Better Buy? - Barchart.com

May 28, 2025

May 26, 2025

Where are the Opportunities in (ADMA) - news.stocktradersdaily.com

May 26, 2025

May 25, 2025

Cetera Investment Advisers Decreases Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World

May 25, 2025

May 23, 2025

Adma Biologics director sells $182,635 in common stock - Investing.com Australia

May 23, 2025

May 23, 2025

Adma Biologics director sells $182,635 in common stock By Investing.com - Investing.com South Africa

May 23, 2025

May 23, 2025

Bank of America Corp DE Has $13.14 Million Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World

May 23, 2025

May 23, 2025

Exploring High Growth Tech Stocks In The US May 2025 - Yahoo

May 23, 2025

May 22, 2025

Are Options Traders Betting on a Big Move in ADMA Biologics Stock? - The Globe and Mail

May 22, 2025

May 20, 2025

BNP Paribas Financial Markets Sells 674,016 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World

May 20, 2025

May 19, 2025

Ameriprise Financial Inc. Acquires 88,542 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World

May 19, 2025

May 18, 2025

These 5 Buy-Ranked Mid-Cap Stocks Are Flying High Year to Date - The Globe and Mail

May 18, 2025

May 16, 2025

(ADMA) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

May 16, 2025

May 13, 2025

FY2025 EPS Estimates for ADMA Biologics Decreased by Analyst - Defense World

May 13, 2025

May 12, 2025

Amid Bumpy Biotech Trade, I'm Eyeing These Two Stocks - TheStreet Pro

May 12, 2025

May 11, 2025

Decoding ADMA Biologics Inc (ADMA): A Strategic SWOT Insight - GuruFocus

May 11, 2025

May 11, 2025

ADMA Biologics (NASDAQ:ADMA) Rating Lowered to “Sell” at StockNews.com - Defense World

May 11, 2025

May 09, 2025

PBYI Stock Rises as Q1 Earnings and Sales Beat Estimates - The Globe and Mail

May 09, 2025

May 09, 2025

Revenue Gains, Bold Guidance Lift ADMA Shares - FXEmpire

May 09, 2025

May 09, 2025

Adma Biologics (ADMA) Misses Q1 Earnings and Revenue Estimates - MSN

May 09, 2025

May 09, 2025

ADMA Biologics: Ready For More Growth Despite Q1 Earnings Miss (NASDAQ:ADMA) - Seeking Alpha

May 09, 2025

May 09, 2025

ADMA Biologics Reports Strong Growth and Strategic Advances - TipRanks

May 09, 2025

May 08, 2025

ADMA Biologics (ADMA) Receives Price Target Upgrade from Raymond - GuruFocus

May 08, 2025

May 08, 2025

ADMA Biologics (ADMA) Receives Price Target Upgrade from Raymond James | ADMA Stock News - GuruFocus

May 08, 2025

May 08, 2025

ADMA's Q1 Earnings and Revenues Miss: Buy, Sell or Hold the Stock? - Yahoo Finance

May 08, 2025

May 08, 2025

Why IBD 50's No. 2 Stock, ADMA Biologics, Just Plummeted By Double Digits - MSN

May 08, 2025

May 08, 2025

Crude Oil Gains Over 2%; US Foods Posts Downbeat Earnings - Benzinga

May 08, 2025

May 08, 2025

Adma Biologics price target raised to $32 from $25 at Raymond James - TipRanks

May 08, 2025

May 08, 2025

Raymond James Increases Price Target for ADMA Biologics | ADMA Stock News - GuruFocus

May 08, 2025

May 08, 2025

ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2025 Earnings Call Transcript - Insider Monkey

May 08, 2025

May 08, 2025

ADMA Biologics Inc (ADMA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

May 08, 2025

May 08, 2025

ADMA Biologics Inc (ADMA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Initiatives Propel Future Outlook - GuruFocus

May 08, 2025

May 08, 2025

Adma Biologics: Q1 Earnings Snapshot - New Haven Register

May 08, 2025

May 08, 2025

ADMA Biologics Reports Strong Q1 2025 Financial Growth - TipRanks

May 08, 2025

May 07, 2025

ADMA Biologics Inc earnings missed by $0.01, revenue topped estimates - Investing.com Nigeria

May 07, 2025

May 07, 2025

ADMA Options Activity Suggests Anticipated Post-Earnings Volatil - GuruFocus

May 07, 2025

May 07, 2025

ADMA Biologics Q1 2025 Earnings: EPS of $0.16 Meets Estimates, R - GuruFocus

May 07, 2025

May 07, 2025

ADMA Biologics Q1 Earnings, Revenue Rise; Shares Fall After Hours - marketscreener.com

May 07, 2025

May 07, 2025

Earnings call transcript: ADMA Biologics Q1 2025 sees revenue beat, mixed stock reaction - Investing.com

May 07, 2025

May 07, 2025

ADMA BIOLOGICS, INC. SEC 10-Q Report - TradingView

May 07, 2025

May 07, 2025

ADMA Biologics (ADMA) Misses Revenue Estimates Despite Strong Growth - GuruFocus

May 07, 2025

May 07, 2025

ADMA Biologics Announces $500M Share Repurchase Program - TipRanks

May 07, 2025

May 07, 2025

ADMA Biologics Q1 2025 Earnings: EPS of $0.16 Meets Estimates, Revenue of $114.8M Misses Expectations - GuruFocus

May 07, 2025

May 07, 2025

Earnings Flash (ADMA) Adma Biologics Posts Q1 Diluted EPS $0.11, vs. FactSet Est of $0.15 - marketscreener.com

May 07, 2025

May 07, 2025

ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

May 07, 2025

May 07, 2025

Adma Biologics options imply 10.9% move in share price post-earnings - TipRanks

May 07, 2025

May 07, 2025

ADMA Options Activity Suggests Anticipated Post-Earnings Volatility | ADMA Stock News - GuruFocus

May 07, 2025